WORLD> America
Apple's silence on chief's health questioned
(Xinhua)
Updated: 2009-06-26 16:46

LOS ANGELES: Analysts and legal experts are questioning whether Apple has run afoul of federal securities rules by keeping silent on its CEO Steve Jobs' health, a newspaper report said on Thursday.

Apple's silence on chief's health questioned
Apple Computer Inc. Chief Executive Officer Steve Jobs holds the new iPhone in this file photo taken in San Francisco, California on January 9, 2007. [Agencies]
Apple's silence on chief's health questioned
Firms aren't required to disclose medical details about executives, but they are required to divulge 'material' information investors should know before buying or selling stock, the Los Angeles Times said, quoting legal experts.

Apple had disclosed in early January that Jobs had a "hormone imbalance" and would take a leave of absence, but never said he was so sick that he needed a liver transplant.

A week later, Jobs admitted that his health issue was "more complex" and would require a six-month leave.

"If they tried to lessen the disclosure and make it misleading by omission, that's just as bad as telling something that flat isn' t true," said Jeffrey C. Soza, a securities lawyer at Glaser, Weil, Fink, Jacobs, Howard & Shapiro in Los Angeles.

The Tennessee doctor who led the transplant team said this week that Jobs was "the sickest patient on the waiting list" at the time a donor liver became available, according to the paper.

Dr. James D. Eason said that Apple's key man had tested high --more likely to die from the condition -- on an index that rates patients with end-stage liver disease.

The revelation of Jobs' illness riled critics because it comes on the heels of long-standing displeasure with Apple's secretive culture and what detractors say is its grudging disclosure of important issues, the paper said.

The Cupertino, California company has maintained that the initial statement was enough to satisfy disclosure rules imposed on publicly traded companies.

Related readings:
Apple's silence on chief's health questioned Hospital confirms Apple chief Jobs had liver transplant
Apple's silence on chief's health questioned Apple CEO Jobs sighted at firm's HQ
Apple's silence on chief's health questioned Apple urged to get to the core of Jobs' health issue
Apple's silence on chief's health questioned Reports: Apple CEO had liver transplant

But some analysts aren't so sure. Intentionally downplaying the extent of such an illness could set Apple on the wrong side of securities laws, Soza said.

Investor Warren E. Buffett agreed that Apple had been less than forthright. "Certainly Steve Jobs is important to Apple," he said in a CNBC-TV interview Wednesday. "Whether he is facing serious surgery or not is a material fact."

The state of Jobs' health has long been a subject of popular discussion, including his surgery for pancreatic cancer in 2004 and his widely observed weight loss that preceded his leave of absence, the paper noted.

With that information in the public sphere, some experts say Apple fulfilled its legal obligation by saying that Jobs was on medical leave.

"His health is a matter of private information, which the board may be in possession of but has no affirmative obligation to disclose," said G. William Speer, a lawyer at Bryan Cave in Atlanta.

Jobs, who founded Apple in 1979, is widely considered a visionary whose products have repeatedly allowed the company to reinvent itself and stay ahead of the competition. His importance to the company fuels the debates on how much information about his health is material for investors.

"Steve is Apple," said Danielle Levitas, an analyst for industry research firm IDC. "The company was on the skids, and he came back to revive them. No doubt, if he were gone, it would be a different company. There aren't a whole lot of people out there like Steve Jobs."

Nor are there many companies whose fate seems so closely tied to that of a single person, said Stephen Davis, a corporate governance expert at Yale University's Millstein Center for Corporate Governance and Performance.

"Whether he's able to come back, in what capacity and when are all highly relevant to Apple's owners," Davis said. "We're in the middle of huge financial crisis that's been caused in part by huge failures of corporate governance. This is an age when you would hope corporations would get that shareholders need some pretty high-quality disclosure."

The Securities and Exchange Commission declined to comment on the situation.